10.24.25 -- Advancing Biologic API And Drug Product Manufacturing Capabilities

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.

This solution supports flexible batch filling for sensitive molecules, radiopharmaceuticals, and advanced therapy needs, from pre-clinical to commercial scale.

Whether you aim to launch your innovative product on a global scale, enhance your formulation, or proactively manage risks, we're here to support your commitments to patients.

Our scalable sterile manufacturing and lyophilization capabilities cover a broad range of small and large molecules across multiple delivery formats, including vials, prefilled syringes, and more.

Hear from Evan Pasenello, Head of Commercial Services, about our ability to support large molecule programs from early phase through clinical and commercial manufacturing.

With a foundation built on operational excellence, cutting-edge technology, and strategic capacity expansion, we’re equipped to overcome the most demanding manufacturing challenges.

We support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.

Our bio-logic brilliance unravels the complexities of ADCs — empowering companies to accelerate development, enhance manufacturing efficiency, and deliver life-changing therapies.

From early development to commercialization, we provide comprehensive support in meeting regulatory expectations for characterization, potency, stability, and safety testing.

This presentation introduces our team's biologics CDMO solutions and capabilities in mammalian cell culture manufacturing and microbial fermentation.